Ophthalmology Futures Retina & European Virtual Forums

Retina – Wednesday 30 September 2020

European – Thursday 01 October 2020

Keith Barton and Kuldev Singh are pleased to announce that our 2020 forums will be going completely virtual this year to maximise participation.

Please click here to find out more.

Ophthalmology Futures Forums are clinician-driven innovation meetings focusing on new technology, entrepreneurial ventures, market access and other aspects of commercialisation in the ophthalmic healthcare sector. They cover all aspects of global innovation in ophthalmic devices, diagnostics and pharmaceuticals by connecting scientists, physicians, regulators, reimbursement specialists, corporate leaders, venture capitalists and other investors who support the advancement of eye care.

Register for the 2020 virtual forums


Retina Forum Provisional Programme

30 September 2020

Virtual Forum

PLEASE NOTE: Times listed below are local Amsterdam times.
Please allow for the time difference in your location, for example:
-1 hour London, – 6 hours Eastern, – 9 hours Pacific
14:20 - 14:30

Welcome from the Co-chairs

14:30 - 15:00

Panel 1: Anti-VEGF Drugs for Retinal Disease: Is There Room for More?

15:00 - 15:30

Panel 2: Can AI Help Us Beyond Retinal Imaging?

15:30 - 16:20

Company Presentations 1

16:20 - 16:50

Panel 3: Gene and Cell-based Therapy for Retinal Disease: Opportunities and Challenges

16:50 - 17:00

Investment Overview

17:00 - 17:30

Panel 4: The Dream Versus the Reality: Making Investments in Retina, an Investor Perspective

17:30 - 18:20

Company Presentations 2

18:20 - 18:50

Panel 5: Surgical Instrumentation and Microscopy: A Real Business or a Revenue Rounding Error

18:50 - 19:20

Panel 6: Novel Drug Delivery Approaches for Posterior Segment Disease

19:20 - 20:10

Company Presentations 3

20:10 - 20:40

Panel 7: The Impact of COVID-19 on Retina Discovery, Development and Business

20:40 - 20:50

Summary

20:50 - 20:55

Concluding Remarks from the Co-chairs

European Forum Provisional Programme

01 October 2020

Virtual Forum

PLEASE NOTE: Times listed below are local Amsterdam times.
Please allow for the time difference in your location, for example:
-1 hour London, – 6 hours Eastern, – 9 hours Pacific
12:30 - 12:40

Welcome from the Co-chairs

Keith Barton
Kuldev Singh

12:40 - 12:50

Market Overview

Michael Giaquinto

12:50 - 13:20

Panel 1: The Global Dry Eye Opportunity: Will it Ever be Realised?

13:20 - 14:20

Company Presentations 1

14:20 - 14:50

Panel 2: Big idea and No Money: Who Do I Call in a Big Company?

14:50 - 15:20

Panel 3: Drug Delivery for Eye Diseases: Simply Cool Technology or also a Commercial Success?

15:20 - 15:50

Panel 4: Cataract and Other Elective Surgery in the Era of COVID-19

15:50 - 16:50

Company Presentations 2

16:50 - 17:20

Panel 5: Refractive Outcomes after Cataract Surgery: IOL Adjustment Vs Enhancement

17:20 - 18:00

Panel 6: Premium IOL Patient-reported Outcomes and Regulatory Processes

Introductory talk and Discussion Panel

Chair: Dr Malvina Eydelman

18:00 - 19:10

Company Presentations 3

19:10 - 19:40

Panel 7: Femto a Decade Later: Was it Worth the Investment?

19:40 - 20:10

Panel 8: Will Endothelial Damage Restrict Glaucoma Device Progression?

20:10 - 20:40

Panel 9: Investment Panel

20:40 - 21:10

A View from the Top: The Long-term Impact of COVID-19 on the Business of Ophthalmology

Chair: James Mazzo

21:10 - 22:05

The Shark Tank

22:05 - 22:10

Summary and Concluding Remarks from Co-chairs

Keith Barton
Kuldev Singh

 

Sponsorship Opportunities

Forum sponsorship opportunities offer organisations of all sizes a unique platform to promote their organisation, products and services to prominent business and scientific leaders. For further information on sponsoring future events, please contact us.

If your organisation would be interested in presenting at one of our Forums, please submit your application via the Apply to Present page.

Sponsorship opportunities are available for our European, Asian and Retina Forums or special rates are available for combined sponsorship. Please contact us for further information or for a sponsorship prospectus.